Biosound unveils new ultrasound units
Biosound Esaote of Indianapolis last month introduced two cardiovascular color flow ultrasound systems. The two new systems, Caris and Megas, were cleared by the Food and Drug Administration last year.Caris, first introduced at the American College of
Biosound Esaote of Indianapolis last month introduced two cardiovascular color flow ultrasound systems. The two new systems, Caris and Megas, were cleared by the Food and Drug Administration last year.
Caris, first introduced at the American College of Cardiology meeting in New Orleans in March, was designed for the mobile market or hospitals that require a second, portable, cardiovascular ultrasound system. Highly portable, Caris is 9 inches high and weighs 35 pounds.
Megas was introduced at this years meeting of the American Society of Echocardiology in Washington, DC, and is aimed at a market segment new to Biosound: the large group, hospital, or clinic that requires a small, low-cost system with phased array cardiovascular technology. According to Biosound, Megas is the only portable phased array cardiovascular ultrasound system in the world. It boasts ASIC and FPGA microcircuitry and uses a 48-pound mainframe. Megas has both conventional and color Doppler, and can be used with a variety of probes, including linear array and convex array technologies.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.
SNMMI: Botox May Facilitate Relief from Dry Mouth Side Effect of PSMA-Targeted Radiopharmaceuticals
June 25th 2025For patients being treated with radiopharmaceutical agents for metastatic prostate cancer, the combination of botulinum toxin and an anti-nausea patch led to a 30 percent reduction in PSMA uptake in the salivary glands, according to preliminary research findings presented at the SNMMI conference.
